Tissue-specific mitochondrial heteroplasmy at position 16,093 within the same individual - PubMed (original) (raw)

Tissue-specific mitochondrial heteroplasmy at position 16,093 within the same individual

Kaarel Krjutškov et al. Curr Genet. 2014 Feb.

Abstract

Human mitochondrial DNA (mtDNA) research has entered a massively parallel sequencing (MPS) era, providing deep insight into mtDNA genomics and molecular diagnostics. Analysis can simultaneously include coding and control regions, many samples can be studied in parallel, and even minor heteroplasmic changes can be detected. We investigated heteroplasmy using 16 different tissues from three unrelated males aged 40-54 years at the time of death. mtDNA was enriched using two independent overlapping long-range PCR amplicons and analysed by employing illumina paired-end sequencing. Point mutation heteroplasmy at position 16,093 (m.16093T > C) in the non-coding regulatory region showed great variability among one of the studied individuals; heteroplasmy extended from 5.1 % in red bone marrow to 62.0 % in the bladder. Red (5.1 %) and yellow bone marrow (8.9 %) clustered into one group and two arteries and two aortas from different locations into another (31.2-50.9 %), giving an ontogenetic explanation for the formation of somatic mitochondrial heteroplasmy. Our results demonstrate that multi-tissue screening using MPS provides surprising data even when there is a limited number (3) of study subjects and they give reason to speculate that mtDNA heteroplasmic frequency, distribution, and even its possible role in complex diseases or phenotypes seem to be underestimated.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Full mtDNA amplification and the confirmation of results. a mtDNA was amplified using two overlapping PCR products, blue and red circles. Average coverage density is shown (green). b Position 16,093 heteroplasmy over the SJ600 body panel. c Sequencing coverage in hypervariable region (HVRI) of D-loop. Coverage in the three different tissues of individual SJ600 is shown. d Sanger sequencing confirmation of position 16,093 heteroplasmy. The percentage is from MPS analysis and chromatogram from Sanger sequencing

Similar articles

Cited by

References

    1. Andrew T, Calloway CD, Stuart S, Lee SH, Gill R, Clement G, Chowienczyk P, Spector TD, Valdes AM. A twin study of mitochondrial DNA polymorphisms shows that heteroplasmy at multiple sites is associated with mtDNA variant 16093 but not with zygosity. PLoS ONE. 2011;6(8):e22332. doi: 10.1371/journal.pone.0022332. - DOI - PMC - PubMed
    1. Avital G, Buchshtav M, Zhidkov I, Tuval Feder J, Dadon S, Rubin E, Glass D, Spector TD, Mishmar D. Mitochondrial DNA heteroplasmy in diabetes and normal adults: role of acquired and inherited mutational patterns in twins. Hum Mol Genet. 2012;1(19):4214–4224. doi: 10.1093/hmg/dds245. - DOI - PMC - PubMed
    1. Goto H, Dickins B, Afgan E, Paul IM, Taylor J, Makova KD, Nekrutenko A. Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study. Genome Biol. 2011;12(6):R59. doi: 10.1186/gb-2011-12-6-r59. - DOI - PMC - PubMed
    1. Guney AI, Ergec DS, Tavukcu HH, Koc G, Kirac D, Ulucan K, Javadova D, Turkeri L. Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer. Genet Test Mol Biomark. 2012;16(7):672–678. doi: 10.1089/gtmb.2011.0227. - DOI - PubMed
    1. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz LA, Jr, Kinzler KW, Vogelstein B, Papadopoulos N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 2010;464(7288):610–614. doi: 10.1038/nature08802. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources